JACC in a Flash

Featured topics and Editors' Picks from all of ACC's JACC Journals.

Journal of the American College of Cardiology
ARISE-HF: Aldose Reductase Inhibitor in Diabetic Cardiomyopathy

Treatment with AT-001, a highly selective aldose reductase inhibitor, had no significant effect on exercise capacity as measured by peak oxygen uptake (VO2) among individuals with diabetic cardiomyopathy, according to results from this Late-Breaking Clinical Trial presented at ACC.24 and simultaneously published in JACC.

Journal of the American College of Cardiology
IMPROVE-HCM: Novel Ninerafaxstat Safe, Effective For Nonobstructive HCM Patients

Ninerafaxstat, a novel cardiac mitotrope that targets energy metabolism, is safe and effective in the treatment of nonobstructive hypertrophic cardiomyopathy (HCM), according to the phase 2 IMPROVE-HCM study, presented during a Late-Breaking Clinical Trial session at ACC.24 and simultaneously published in JACC.

Journal of the American College of Cardiology
VICTORION-INITIATE: "Inclisiran-First" Strategy Yields Greater LDL-C Reduction

In patients with atherosclerotic cardiovascular disease (ASCVD) who have not reached LDL-C levels <70 mg/dL, immediately adding inclisiran led to greater reductions in LDL-C, according to results of the open-label, phase 3b VICTORION-INITIATE study presented during a Featured Clinical Research session at ACC.24 and simultaneously published in JACC.

Journal of the American College of Cardiology
TACTiC: Novel Web Tool For Statin Access?

The majority (>90%) of participants using a novel web application appropriately qualified for treatment with a nonprescription statin, closely matching results of a clinician assessment of eligibility, according to results from TACTiC, presented during a Late-Breaking Clinical Trial session at ACC.24 and simultaneously published in JACC.

Journal of the American College of Cardiology
TELE-ACS: Telemedicine Intervention Reduces Hospital Readmission, ED Visits

A robust telemedicine intervention across six months following an acute coronary syndrome (ACS) was associated with a reduction in hospital readmission, emergency department (ED) visits, unplanned coronary revascularization and patient-reported symptoms, according to a study presented during a Featured Clinical Research session at ACC.24 and simultaneously published in JACC.

Click here to read a news story on more science presented during ACC.24 and published across the JACC Family of Journals.

Click here to read all the articles published simultaneously with ACC. 24 in the JACC Journals.

Clinical Topics: Acute Coronary Syndromes, Heart Failure and Cardiomyopathies

Keywords: Cardiology Magazine, ACC Publications, Diabetic Cardiomyopathies, Acute Coronary Syndrome, Prospective Studies, Cardiomyopathy, Hypertrophic, Hypertrophic Cardiomyopathy